10050 Federal Register / Vol. 74, No. 44 / Monday, March 9, 2009 / Notices 

PACHA Committee Manager is listed 

above. 

Dated: March 3, 2009. 

Christopher H. Bates, 

Interim Executive Director, Presidential 

Advisory Council on HIV/AIDS. 

[FR Doc. E9–4854 Filed 3–6–09; 8:45 am] 

BILLING CODE 4150–43–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Committee to the Director, 

Centers for Disease Control and 

Prevention, (ACD, CDC) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the CDC announces 

the following meeting of the 

aforementioned committee: 

TIME AND DATE: 6 p.m.–7 p.m., March 4, 

2009. 

PLACE: The teleconference call will 

originate at the CDC. Details on 

accessing the teleconference are located 

in the supplementary information. 

STATUS: Open to the public, 

teleconference access limited only by 

availability of telephone ports. 

PURPOSE: The committee will provide 

advice to the Director, CDC on strategic 

and other broad issues facing CDC. 

MATTERS TO BE DISCUSSED: During this 

conference call, the National 

Biosurveillance Advisory Subcommittee 

(NBAS) will provide recommendations 

to the ACD, CDC for transmittal to the 

administration. Since the NBAS was 

created in May, 2008, the subcommittee 

has been on a very aggressive timeline 

in order to provide the administration 

with key recommendations for 

improving the nation’s biosurveillance 

capability. In order for these 

recommendations to go through the 

proper clearance steps and still be 

timely and relevant for the 

administration, the ACD, CDC must 

review and approve these 

recommendations as soon as possible. 

The NBAS was originally scheduled to 

present these recommendations to the 

ACD, CDC at the meeting scheduled for 

February 24, 2009. 

Agenda items are subject to change as 

priorities dictate. 

SUPPLEMENTARY INFORMATION: This 

conference call is scheduled to begin at 

6 p.m. Eastern Standard Time. To 

participate in the teleconference, please 

dial 1–888–323–9787 and enter 

conference code 4735949. 

CONTACT PERSON FOR MORE INFORMATION: 

Brad Perkins, M.D., M.B.A., Designated 

Federal Officer, ACD, CDC, 1600 Clifton 

Road, NE., M/S D–14, Atlanta, Georgia 

30333. Telephone: 404–639–7000. 

The ACD, CDC was scheduled to meet 

by conference call on February 24, 2009. 

The meeting was postponed on short 

notice because of quorum guidelines. 

The meeting is re-scheduled for March 

4, 2009, at 6 p.m., as this is the only 

available time to gather a quorum of the 

ACD members. 

This notice is being published less 

than 15 days prior to the meeting due 

to the scheduling difficulties 

encountered when planning the 

meeting, and due to the urgent nature of 

transmitting the recommendations to 

the administration. 

The Director, Management Analysis 

and Services office has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities for both the CDC 

and the Agency for Toxic Substances 

and Disease Registry. 

Andre Tyler, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention (CDC). 

[FR Doc. E9–4940 Filed 3–4–09; 4:15 pm] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–R–245] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services. 

In compliance with the requirement 

of section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995, the 

Centers for Medicare & Medicaid 

Services (CMS), Department of Health 

and Human Services, is publishing the 

following summary of proposed 

collections for public comment. 

Interested persons are invited to send 

comments regarding this burden 

estimate or any other aspect of this 

collection of information, including any 

of the following subjects: (1) The 

necessity and utility of the proposed 

information collection for the proper 

performance of the Agency’s function; 

(2) the accuracy of the estimated 

burden; (3) ways to enhance the quality, 

utility, and clarity of the information to 

be collected; and (4) the use of 

automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

1. Type of Information Collection 

Request: Revision of a currently 

approved collection; Title of 

Information Collection: Medicare and 

Medicaid Programs OASIS Collection 

Requirements as Part of the CoPs for 

HHAs and Supporting Regulations in 42 

CFR, Sections 484.55, 484.205, 484.245, 

484.250; Use: The Centers for Medicare 

& Medicaid Services is requesting OMB 

approval to modify the Outcome and 

Assessment Information Set (OASIS) 

data set that home health agencies 

(HHAs) are required to collect in order 

to participate in the Medicare program. 

Proposed revisions to the OASIS data 

set include: (1) Issues raised by 

stakeholders, including removing items 

that are not currently used by CMS for 

payment or quality, adding items to 

address clinical domains not currently 

covered, and modifying item wording or 

response categories for selected items; 

and (2) the addition of process items 

that support measurement of evidencebased practices. Proposed revisions to 

OASIS items address issues raised by 

stakeholders, including removing items 

that are not currently used by CMS for 

payment or quality, adding items to 

address clinical domains not currently 

covered, and modifying item wording or 

response categories for selected items. 

These changes and item deletions are 

considered to be high priority by CMS 

and have implications for outcome 

measurement, risk adjustment of 

outcome reports, case mix adjustment 

for prospective payment, data 

submission procedures and 

specifications, reporting systems, and 

provider paperwork burden. 

In addition, adopting measures of 

efficient and high-quality care is central 

to the direction that CMS would like to 

take in its Quality Initiative. In 

accordance with long-standing Federal 

objectives, CMS ultimately plans to 

create a standard patient assessment 

instrument that can be used across all 

post-acute care settings. The revision of 

the OASIS instrument is an opportunity 

to consider various components of 

quality care and how patients might be 

better served as they (and information 

about them and their care) move among 

health care settings. For this reason, the 

OASIS C includes process items that 

support measurement of evidence-based 

practices across the post-acute care 

spectrum that have been shown to 

prevent exacerbation of serious 

conditions, can improve care received 

by individual patients, and can provide 


dwashington3 on PROD1PC60 with NOTICES
Federal Register / Vol. 74, No. 44 / Monday, March 9, 2009 / Notices 10051 

guidance to agencies on how to improve 

care and avoid adverse events. Form 

Number: CMS–R–245 (OMB# 0938– 

0760); Frequency: Occasionally; 

Affected Public: Business or other forprofit and not-for-profit institutions; 

Number of Respondents: 10,170; Total 

Annual Responses: 14,960,070; Total 

Annual Hours: 15,590,610. 

To obtain copies of the supporting 

statement and any related forms for the 

proposed paperwork collections 

referenced above, access CMS Web site 

address at http://www.cms.hhs.gov/ 

PaperworkReductionActof1995, or Email your request, including your 

address, phone number, OMB number, 

and CMS document identifier, to 

Paperwork@cms.hhs.gov, or call the 

Reports Clearance Office on (410) 786– 

1326. 

To be assured consideration, 

comments and recommendations for the 

proposed information collections must 

be received by the OMB desk officer at 

the address below, no later than 5 p.m. 

on April 8, 2009. 

OMB, Office of Information and 

Regulatory Affairs 

Attention: CMS Desk Officer. 

Fax Number: (202) 395–6974. 

E-mail: 

OIRA_submission@omb.eop.gov. 

Dated: March 3, 2009. 

Michelle Shortt, 

Director, Regulations Development Group, 

Office of Strategic Operations and Regulatory 

Affairs. 

[FR Doc. E9–4883 Filed 3–6–09; 8:45 am] 

BILLING CODE 4120–01–U–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Proposed Information Collection 

Activity; Comment Request 

Proposed Projects: 

Title: Developmental Disabilities 

Program Independent Evaluation 

Project. 

OMB No.: New collection. 

Description: The Developmental 

Disabilities Program Independent 

Evaluation (DDPIE) Project is an 

independent (non-biased) evaluation to 

examine through rigorous and 

comprehensive performance-based 

research procedures the targeted impact 

on the lives of people with 

developmental disabilities and their 

families of three programs funded under 

the Developmental Disabilities 

Assistance and Bill of Rights Act of 

2000 (DD Act): (1) State Councils on 

Developmental Disabilities (SCDDs); (2) 

State Protection and Advocacy Systems 

for Individuals with developmental 

disabilities (P & As); and (3) University 

Centers for Excellence in Developmental 

Disabilities (UCEDDs). The intent of this 

evaluation is to understand and report 

on the accomplishments of these 

programs, including collaborative efforts 

among the DD Network programs. The 

results of this evaluation will provide a 

report to the Administration on 

Developmental Disabilities (ADD) (the 

agency that administers these programs) 

with information on the effectiveness of 

its programs and policies and serve as 

a way for ADD to promote 

accountability to the public. 

The independent evaluation is a 

response to accountability requirements 

for ADD as identified in the 

Developmental Disabilities Assistance 

and Bill of Rights Act of 2000 (DD Act), 

the Government Performance and 

Results Act (GPRA) of 1993, and the 

Program Assessment Rating Tool 

(PART), administered by the Office of 

Management and Budget (OMB). This 

project meets the requirements of PART 

by providing a non-biased method of 

evaluating the effectiveness and impact 

of DD Network programs on the lives of 

people with developmental disabilities 

and their families. 

ADD is seeking OMB approval for the 

evaluation tools (e.g., data collection 

instruments). The evaluation tools are 

designed to collect data for two 

purposes: (1) To measure the programs 

according to indicators (structural, 

process, output, and outcome) in key 

function areas; and (2) to establish 

performance standards for measuring 

the impact of each of the programs. The 

evaluation tools are primarily protocols 

for conducting interviews with various 

staff of the three programs and 

stakeholders associated with the 

programs. The interview protocols were 

tested during a pilot study in 2008. 

There is also a self-administered form 

for each of the programs to be 

completed by Executive Directors or 

his/her designee. The self-administered 

form was developed as a result of the 

pilot study and, therefore, has not been 

tested for reliability and validity. It is 

intended that the clearance process will 

be a mechanism for determining the 

reliability, validity, and feasibility of 

using this instrument. 

Respondents: Staff of State Councils 

on Developmental Disabilities, State 

Protection and Advocacy Systems for 

Indiviiduals with developmental 

disabilities, and University Centers for 

Excellence in Developmental 

Disabilities, Education, Research, and 

Service; individuals with 

developmental disabilities; parents of 

individuals with developmental 

disabilities; siblings of individuals with 

developmental disabilities; guardians; 

advocates; policymakers; service 

providers; university faculty; and others 

(e.g., DDC chairs, members of Protection 

and Advocacy boards of directors or 

commissioners; Consumer Advisory 

Committee members). 

ANNUAL BURDEN ESTIMATES

Instrument Number of 

respondents 

Number of 

responses per 

respondent 

Average burden 

hours per 

response 

Total burden 

hours 

DD Council: Executive Director Interview ...................................................... 20 1 4 80 

DD Council: Interview with Council Chair/Council Members ........................ 60 1 0 .75 45 

DD Council: Group Interview with Policymakers, Collaborators, and Grantees .............................................................................................................. 160 1 2 320 

DD Council: Group Interview with Recipients of Self-Advocacy and Leadership Education and Training ................................................................... 100 1 0 .75 75 

DD Council: Group Interview with Recipients of Education and Training to 

Improve Community Capacity .................................................................... 100 1 0 .75 75 

DD Council: Self-administered Form ............................................................. 20 1 8 160 

P&A: Executive Director Interview ................................................................. 20 1 4 80 

P&A: Staff Interview ....................................................................................... 60 1 0 .75 45 


dwashington3 on PROD1PC60 with NOTICES